This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

WILLIAM CARPENTER MacCARTY, M.D.

Arch Intern Med. 1928;41(4):536-548.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

During the last twenty-five years, surgeons have attempted to add surgical treatment to other forms of therapy in many conditions characterized by anemia and splenomegaly. They have, therefore, applied splenectomy in advanced, and in some early, cases of splenic anemia, hepatic cirrhosis, hemolytic icterus, pernicious anemia, myelogenous leukemia, Gaucher's¹ disease, and recently, to hemorrhagic purpura. Their efforts have been beneficial in splenic anemia, hemolytic icterus and hemorrhagic purpura, but rather unsatisfactory in pernicious anemia and in myelogenous leukemia. Occasionally splenectomy in hepatic cirrhosis is followed by improvement. Removal of the spleen as a therapeutic procedure has been based on the facts that it may be removed without definite damage to life; that this organ may be a factor in the destruction of blood in some cases of anemia; that any tumor which interferes with the vital functions of other organs should be removed, and that splenectomy empirically performed in hemorrhagic . . . [Full Text PDF of this Article]

Author Affiliations
ROCHESTER, MINN.

Footnotes
Read before the Section on Pathology and Physiology at the Annual Session of the American Medical Association, Washington, D. C., May, 1927.

A preliminary report.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?